Southeastern Digestive & Liver Disease
Savannah, Georgia, United States
Gastroenterologist in Savannah, Georgia
1139 Lexington Ave, Savannah, GA 31404
About Southeastern Digestive & Liver Disease
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Abbott
3
SciClone Pharmaceuticals
2
Clinical Trials at Southeastern Digestive & Liver Disease
During the past decade, Southeastern Digestive & Liver Disease conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
2002-05-01
Completed
500
Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
2002-04-01
Completed
500
A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
2002-04-01
Completed
300
Remission in Subjects With Crohn's Disease, Open Label Extension
2002-08-01
2008-12-01
Completed
177
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Southeastern Digestive & Liver Disease
According to Clinical.Site data, the most researched conditions in "Southeastern Digestive & Liver Disease" are
"Crohn's Disease" (3 trials), "Hepatitis C" (2 trials) and "Hepatitis C, Chronic" (2 trials). Many other conditions were trialed in "Southeastern Digestive & Liver Disease" in a lesser frequency.
Clinical Trials Intervention Types at Southeastern Digestive & Liver Disease
Most popular intervention types in "Southeastern Digestive & Liver Disease" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Adalimumab (D2E7)" (1 trials), "Adalimumab 40 mg eow or ew" (1 trials), "DB adalimumab 40 mg eow" (1 trials), "DB adalimumab 40 mg ew" (1 trials) and "Double-blind (DB) adalimumab placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Southeastern Digestive & Liver Disease
The vast majority of trials in "Southeastern Digestive & Liver Disease" are
5 trials for "All" genders.
Clinical Trials Status at Southeastern Digestive & Liver Disease
Currently, there are NaN active trials in "Southeastern Digestive & Liver Disease".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Southeastern Digestive & Liver Disease,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Southeastern Digestive & Liver Disease, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".